Insulin as an Effector of Human Ovarian and Adrenal Steroid Metabolism

John E. Nestler1, Jerome F. Strauss2
1Associate Professor of Medicine, Department of Medicine, Division of Endocrinology and Metabolism, Medical College of Virginia/Virginia Commonwealth University, Richmond, Virginia
2Professor of Obstetrics and Gynecology, and Associate Chairman, Department of Obstetrics and Gynecology, University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania

Tài liệu tham khảo

Abraham, 1974, Ovarian and adrenal contribution to peripheral androgens during the menstrual cycle, J Clin Endocrinol Metab, 39, 340, 10.1210/jcem-39-2-340 Adashi, 1982, Insulin augmentation of testosterone production in a primary culture of rat testicular cells, Biol Reprod, 26, 270, 10.1095/biolreprod26.2.270 Barbieri, 1983, Hyperandrogenism, insulin resistance, and acanthosis nigricans syndrome: A common endocrinopathy with distinct pathophysiologic features, Am J Obstet Gynecol, 147, 90, 10.1016/0002-9378(83)90091-1 Barbieri, 1986, Insulin stimulates androgen accumulation in incubations of ovarian stroma obtained from women with hyperandrogenism, J Clin Endocrinol Metab, 62, 904, 10.1210/jcem-62-5-904 Barbieri, 1988, The role of hyperinsulinemia in the pathogenesis of ovarian hyperandrogenism, Fertil Steril, 50, 197, 10.1016/S0015-0282(16)60060-2 Barbieri, 1988, Hyperinsulinemia and ovarian hyperandrogenism. Cause and effect, Endocrinol Metab Clin North Am, 17, 685, 10.1016/S0889-8529(18)30405-5 Barnes, 1989, Pituitary-ovarian responses to nafarelin in the polycystic ovary syndrome, N Engl J Med, 320, 559, 10.1056/NEJM198903023200904 Bates, 1982, Effect of body weight reduction on plasma androgens in obese, infertile women, Fertil Steril, 38, 406, 10.1016/S0015-0282(16)46571-4 Baxter, 1987, Diurnal rhythm of growth hormone—independent binding protein for insulin-like growth factors in human plasma, J Clin Endocrinol Metab, 62, 432, 10.1210/jcem-65-3-432 Blanco, 1981, The effect of insulin and luteinizing hormone treatment on serum concentrations of testosterone and dihydrotestosterone and testicular 3β-hydroxysteroid dehydrogenase activity in intact and hypophysectomized diabetic rats, Endocrinology, 109, 1248, 10.1210/endo-109-4-1248 Blay, 1989, The nature and function of polypeptide growth factor receptors in the human placenta, J Dev Physiol, 12, 237 Burghen, 1980, Correlation of hyperandrogenism with hyperinsulinism in polycystic ovarian disease, J Clin Endocrinol Metab, 50, 113, 10.1210/jcem-50-1-113 Cara, 1988, Insulin-like growth factor I and insulin potentiate luteinizing hormone-induced androgen synthesis by rat ovarian thecal-interstitial cells, Endocrinology, 123, 733, 10.1210/endo-123-2-733 Cara, 1990, Insulin-like growth factor-I enhances luteinizing hormone binding to rat ovarian theca-interstitial cells, J Clin Invest, 86, 560, 10.1172/JCI114745 Chang, 1983, Insulin resistance in nonobese patients with polycystic ovarian disease, J Clin Endocrinol Metab, 57, 356, 10.1210/jcem-57-2-356 Conover, 1990, Insulin regulation of insulin-like growth factor-binding protein production in cultured HepG2 cells, J Clin Endocrinol Metab, 70, 1062, 10.1210/jcem-70-4-1062 Diamond, 1991, Effect of acute physiological elevations of insulin on circulating androgen levels in nonobese women, J Clin Endocrinol Metab, 72, 883, 10.1210/jcem-72-4-883 Dunaif, 1988, The impact of obesity and chronic hyperinsulinemia on gonadotropin release and gonadal steroid secretion in the polycystic ovary syndrome, J Clin Endocrinol Metab, 66, 131, 10.1210/jcem-66-1-131 Dunaif, 1989, Insulin administration alters gonadal steroid metabolism independent of changes in gonadotropin secretion in insulin resistant women with the polycystic ovary syndrome, J Clin Invest, 83, 23, 10.1172/JCI113864 Dunaif, 1989, Profound peripheral insulin resistance, independent of obesity, in polycystic ovary syndrome, Diabetes, 38, 1165, 10.2337/diab.38.9.1165 Dunaif, 1990, Suppression of hyperandrogenism does not improve peripheral or hepatic insulin resistance in the polycystic ovary syndrome, J Clin Endocrinol Metab, 70, 699, 10.1210/jcem-70-3-699 Erickson, 1990, The effects of insulin and insulin-like growth factors-I and -II on estradiol production by granulosa cells of polycystic ovaries, J Clin Endocrinol Metab, 70, 894, 10.1210/jcem-70-4-894 Falcone, 1990, Androgen response to endogenous insulin secretion during the frequently sampled intravenous glucose tolerance test in normal and hyperandrogenic women, J Clin Endocrinol Metab, 71, 1653, 10.1210/jcem-71-6-1653 Farah, 1990, Bimodal correlation between the circulating insulin level and the production rate of dehydroepiandrosterone: Positive correlation in controls and negative correlation in the polycystic ovary syndrome with acanthosis nigricans, J Clin Endocrinol Metab, 70, 1075, 10.1210/jcem-70-4-1075 Flier, 1985, Acanthosis nigricans in obese women with hyperandrogenism. Characterization of an insulin-resistant state distinct from the Type A and B syndromes, Diabetes, 34, 101, 10.2337/diab.34.2.101 Garzo, 1984, Aromatase activity in human granulosa cells during follicular development and the modulation of follicle-stimulating hormone and insulin, Am J Obstet Gynecol, 148, 657, 10.1016/0002-9378(84)90769-5 Gates, 1987, Characterization of insulin-like growth factor I binding to human granulosa cells obtained during in vitro fertilization, J Recept Res, 7, 885, 10.3109/10799898709054568 Geffner, 1986, Persistence of insulin resistance in polycystic ovarian disease after inhibition of ovarian steroid secretion, Fertil Steril, 45, 327, 10.1016/S0015-0282(16)49211-3 Givens, 1988, Familial polycystic ovarian disease, Endocrinol Metab Clin North Am, 17, 771, 10.1016/S0889-8529(18)30409-2 Grunberger, 1988, Insulin receptors in normal and disease states, Clin Endocrinol Metab, 12, 191, 10.1016/S0300-595X(83)80036-X Gulati, 1989, The effect of the insulin mediator on the metabolism of androst-4-ene-3,17-dione in isolated rat hepatocytes, Biochem Pharmacol, 38, 4415, 10.1016/0006-2952(89)90650-3 Haffner, 1988, The relationship of sex hormones to hyperinsulinemia and hyperglycemia, Metabolism, 37, 683, 10.1016/0026-0495(88)90091-1 Harlass, 1984, Weight loss is associated with correction of gonadotropin and sex steroid abnormalities in the obese anovulatory female, Fertil Steril, 42, 649, 10.1016/S0015-0282(16)48154-9 Hernandez, 1988, Somatomedin-C/insulin-like growth factor I as an enhancer of androgen biosynthesis by cultured rat ovarian cells, Endocrinology, 122, 1603, 10.1210/endo-122-4-1603 Hubert GD, Schriock ED, Givens JR, et al: Insulin suppression of adrenal androgen concentrations during glucose tolerance testing in normal women [abstract 31]. In Scientific Program and Abstracts for the 37th Annual Meeting of the Society for Gynecologic Investigation, 1990, p 112 Hussin, 1987, The effect of insulin on steroid metabolism in isolated rat hepatocytes, Biochem Pharmacol, 36, 3155, 10.1016/0006-2952(87)90626-5 Imperato-McGinley, 1978, Primary amenorrhea associated with hirsutism, acanthosis nigricans, dermoid cysts of the ovaries and a new type of insulin resistance, Am J Med, 65, 389, 10.1016/0002-9343(78)90838-0 Jarrett, 1985, Insulin binding to human ovaries, J Clin Endocrinol Metab, 60, 460, 10.1210/jcem-60-3-460 Kahn, 1976, The syndrome of insulin resistance and acanthosis nigricans, N Engl J Med, 294, 739, 10.1056/NEJM197604012941401 Kiddy, 1990, Differences in clinical and endocrine features between obese and non-obese subjects with polycystic ovary syndrome: An analysis of 263 consecutive cases, Clin Endocrinol (Oxf), 32, 213, 10.1111/j.1365-2265.1990.tb00857.x Koistinen, 1990, Human granulosa cells contain insulin-like growth factor-binding protein (IGF BP-1) mRNA, Clin Endocrinol (Oxf), 32, 635, 10.1111/j.1365-2265.1990.tb00907.x Kramer, 1990, Differential modulation of ACTH-stimulated cortisol and androstenedione secretion by insulin, J Steroid Biochem, 36, 33, 10.1016/0022-4731(90)90111-5 Liu, 1990, Marked attenuation of ultradian and circadian rhythms of dehydroepiandrosterone in postmenopausal women: Evidence for a reduced 17,20-desmolase enzymatic activity, J Clin Endocrinol Metab, 71, 900, 10.1210/jcem-71-4-900 McClanahan, 1990, Insulin inhibits adrenal 17,20-lyase activity, Clin Res, 38, 979A Micic, 1988, Androgen levels during sequential insulin euglycemic clamp studies in patients with polycystic ovary disease, J Steroid Biochem, 31, 995, 10.1016/0022-4731(88)90344-5 Migeon, 1957, Dehydroepiandrosterone and androsterone levels in human plasma. Effect of age and sex; day-to-day and diurnal variations, J Clin Endocrinol Metab, 17, 1051, 10.1210/jcem-17-9-1051 Möller, 1988, Detection of an alteration in the insulin-receptor gene in a patient with insulin resistance, acanthosis nigricans, and the polycystic ovary syndrome (Type A insulin resistance), N Engl J Med, 319, 1526, 10.1056/NEJM198812083192306 Morley, 1989, Insulin enhances luteinizing hormone-stimulated steroidogenesis by porcine theca cells, Biol Reprod, 40, 735, 10.1095/biolreprod40.4.735 Nagamani, 1986, Hyperinsulinemia in hyperthecosis of the ovaries, Am J Obstet Gynecol, 154, 384, 10.1016/0002-9378(86)90676-9 Nestler, 1987, Modulation of aromatase and P450 cholesterol side-chain cleavage enzyme activities of human placental cytotrophoblasts by insulin and insulin-like growth factor I, Endocrinology, 121, 1845, 10.1210/endo-121-5-1845 Nestler, 1987, The effects of hyperinsulinemia on serum testosterone, progesterone, dehydroepiandrosterone sulfate, and cortisol levels in normal women and in a woman with hyperandrogenism, insulin resistance, and acanthosis nigricans, J Clin Endocrinol Metab, 64, 180, 10.1210/jcem-64-1-180 Nestler, 1989, Insulin and insulin-like growth factor I stimulate the 3β-hydroxysteroid dehydrogenase activity of human placental cytotrophoblasts, Endocrinology, 125, 2127, 10.1210/endo-125-4-2127 Nestler, 1989, The central role of obesity (hyperinsulinemia) in the pathogenesis of the polycystic ovary syndrome, Am J Obstet Gynecol, 161, 1095, 10.1016/0002-9378(89)90640-6 Nestler, 1989, Suppression of serum insulin by diazoxide reduces serum testosterone levels in obese women with polycystic ovary syndrome, J Clin Endocrinol Metab, 68, 1027, 10.1210/jcem-68-6-1027 Nestler, 1989, Suppression of serum dehydroepiandroster one sulfate levels by insulin: An evaluation of possible mechanisms, J Clin Endocrinol Metab, 69, 1040, 10.1210/jcem-69-5-1040 Nestler, 1990, Increased transcapillary escape rate of albumin in nondiabetic men in response to hyperinsulinemia, Diabetes, 39, 1212, 10.2337/diab.39.10.1212 Nestler, 1990, Suppression of serum insulin by diazoxide does not alter serum testosterone or sex hormone-binding globulin levels in healthy nonobese women, Am J Obstet Gynecol, 163, 1243, 10.1016/0002-9378(90)90698-7 Nestler, 1991, A direct effect of hyperinsulinemia on serum sex hormone-binding globulin levels in obese women with the polycystic ovary syndrome, J Clin Endocrinol Metab, 72, 83, 10.1210/jcem-72-1-83 Nestler JE, Romero G, Huang LC, Zhang C, Larner J: Insulin mediators are the signal transduction system responsible for insulin’s actions on human placental steroidogenesis. Endocrinology 129: in press (December 1991) Nissley, 1984, Somatomedin/insulin-like growth factor tissue receptors, Clin Endocrinol Metab, 13, 43, 10.1016/S0300-595X(84)80008-0 Orentreich, 1984, Age changes and sex differences in serum dehydroepiandrosterone sulfate concentrations throughout adulthood, J Clin Endocrinol Metab, 59, 551, 10.1210/jcem-59-3-551 Pardridge, 1986, Serum bioavailability of sex steroid hormones, Clin Endocrinol Metab, 15, 259, 10.1016/S0300-595X(86)80024-X Parker, 1989, Control of adrenal androgen secretion, 355 Pasquali, 1983, Insulin resistance in patients with polycystic ovaries: Its relationship to body weight and androgen levels, Acta Endocrinol (Copenh), 104, 110, 10.1530/acta.0.1040110 Pasquali, 1986, Effect of weight loss and antiandrogenic therapy on sex hormone blood levels and insulin resistance in obese patients with polycystic ovaries, Am J Obstet Gynecol, 154, 139, 10.1016/0002-9378(86)90410-2 Peiris, 1989, The relationship of insulin to sex hormone binding globulin: Role of adiposity, Fertil Steril, 52, 69, 10.1016/S0015-0282(16)60791-4 Pekonen, 1989, Decreased 34K insulin-like growth factor binding protein in polycystic ovarian disease, Fertil Steril, 51, 972, 10.1016/S0015-0282(16)60728-8 Plymate, 1981, Obesity and its role in polycystic ovary syndrome, J Clin Endocrinol Metab, 52, 1246, 10.1210/jcem-52-6-1246 Plymate, 1988, Inhibition of sex hormone-binding globulin production in the human hepatoma (Hep G2) cell line by insulin and prolactin, J Clin Endocrinol Metab, 67, 460, 10.1210/jcem-67-3-460 Poretsky, 1984, Specific insulin binding sites in human ovary, J Clin Endocrinol Metab, 59, 809, 10.1210/jcem-59-4-809 Poretsky, 1987, The gonadotropic function of insulin, Endocr Rev, 8, 132, 10.1210/edrv-8-2-132 Poretsky, 1985, Distribution and characterization of insulin and insulin-like growth factor I receptors in normal human ovary, J Clin Endocrinol Metab, 61, 728, 10.1210/jcem-61-4-728 Poretsky, 1990, Type I insulin-like growth factor receptors in human ovarian stroma, Horm Res, 33, 22, 10.1159/000181441 Poretsky, 1990, Regulation of human ovarian insulin receptors in vivo, Metabolism, 39, 161, 10.1016/0026-0495(90)90070-S Reed, 1989, Regulation of steroid synthesis and metabolism by growth factors, Clin Endocrinol (Oxf), 31, 511, 10.1111/j.1365-2265.1989.tb01275.x Richards, 1985, Obesity, acanthosis nigricans, insulin resistance, and hyperandrogenemia: Pediatric perspective and natural history, I Pediatr, 107, 893, 10.1016/S0022-3476(85)80182-7 Rosenfield, 1990, Dysregulation of cyctochrome P450cl7a as the cause of polycystic ovary syndrome, Fertil Steril, 53, 785, 10.1016/S0015-0282(16)53510-9 Rowe, 1981, Effect of insulin and glucose infusions on sympathetic nervous system activity in normal man, Diabetes, 30, 219, 10.2337/diab.30.3.219 von Schoultz, 1989, On the regulation of sex-hormone-binding globulin—a challenge of an old dogma and outlines of an alternative mechanism, J Steroid Biochem, 32, 327, 10.1016/0022-4731(89)90272-0 Seppälä, 1984, Human preovulatory follicular fluid, luteinized cells of hyperstimulated preovulatory follicles, and corpus luteum contain placental protein 12, J Clin Endocrinol Metab, 58, 505, 10.1210/jcem-58-3-505 Shoupe, 1983, Insulin resistance in polycystic ovary syndrome, Am J Obstet Gynecol, 147, 588, 10.1016/0002-9378(83)90023-6 Shoupe, 1984, The influence of androgens on insulin resistance, Fertil Steril, 41, 385, 10.1016/S0015-0282(16)47716-2 Smith, 1987, Androgen and insulin response to an oral glucose challenge in hyperandrogenic women, Fertil Steril, 48, 72, 10.1016/S0015-0282(16)59293-0 Stuart, 1986, Insulin resistance with acanthosis nigricans: The roles of obesity and androgen excess, Metabolism, 35, 197, 10.1016/0026-0495(86)90201-5 Stuart, 1987, Hyperinsulinemia and hyperandrogenemia: in vivo response to insulin infusion, Obstet Gynecol, 69, 921 Suikkari, 1988, Insulin regulates the serum levels of low molecular weight insulin-like growth factor-binding protein, J Clin Endocrinol Metab, 66, 266, 10.1210/jcem-66-2-266 Suikkari, 1989, Low levels of low molecular weight insulin-like growth factor-binding protein in patients with polycystic ovarian disease, Hum Reprod, 4, 136, 10.1093/oxfordjournals.humrep.a136858 Taylor, 1982, Insulin resistance associated with androgen excess in women with autoantibodies to the insulin receptor, Ann Intern Med, 97, 851, 10.7326/0003-4819-97-6-851 Veldhuis, 1983, Mechanisms subserving the trophic actions of insulin on ovarian cells, J Clin Invest, 72, 1046, 10.1172/JCI111029 Veldhuis, 1986, Insulin regulates low-density lipoprotein binding and degradation by swine granulosa cells, Endocrinology, 118, 2242, 10.1210/endo-118-6-2242 Veldhuis, 1986, The insulin-like growth factor, somatomedin C, induces the synthesis of cholesterol side-chain cleavage cytochrome P-450 and adrenodoxin in ovarian cells, J Biol Chem, 261, 2499, 10.1016/S0021-9258(17)35812-X Yen, 1980, The polycystic ovary syndrome, Clin Endocrinol (Oxf), 12, 177, 10.1111/j.1365-2265.1980.tb02132.x Yoshimasa, 1988, Insulin-resistant diabetes due to a point mutation that prevents insulin proreceptor processing, Science, 240, 784, 10.1126/science.3283938